LNC Therapeutics announces the deployment of a research platform focused exclusively on its gut...
Jun 6, 2019more +
LNC Therapeutics announces the grant of the first worldwide patent relating to the therapeutic...
Mar 26, 2019more +
Dr. Mathieu Simon and Catherine Combot-Plétan join the Board of Directors of biotech firm LNC...
Dec 11, 2018more +
LNC Therapeutics acquires exclusive license for the Christensenella patent from Cornell University
Oct 15, 2018more +
LNC Therapeutics launches a new clinical trial, OBEMINALE 2, and treats its first patient
Oct 2, 2018more +
Christensenella: the cornerstone of the gut microbiota?
Jul 6, 2018more +